Israel Active

Israel’s emergency service Magen David Adom in Jerusalem has introduced unique ICU motorcycles. These are fully equipped with rescue and ICU capabilities so that MDA paramedics can get to patients faster and stabilize them until ambulances arrive to evacuate them to hospital.

Israel is a pioneer of the medical properties of cannabis / marijuana. A study by scientists at Tel Aviv University and Kfar Saba’s Meir Hospital has shown it to give Crohns’ disease sufferers significant relief from their symptoms. Some of them said the disease went into remission. An estimated 0.3 percent of the general population suffers from Crohn's disease.

Another Israeli medical products mentioned last week is the UNFO foot brace. The device is worn below the ankle and rectifies infant foot deformities (metatarsus adductus or metatarsus varus) within six weeks. It is far superior, safer, and less stressful than a cast or full leg braces.

Tel Aviv University researchers have succeeded in isolating a protein known as Gene 0.4 that kills bacteria. In what is a first step toward developing a substitute for antibiotics, the protein prevents bacteria from dividing, thus destroying them and combating infections. A positive story from Haaretz!

Hebrew speakers can get medical guidance direct from Israel’s emergency service Magen David Adom via their cell phone. After downloading the app, they don’t need Internet access. Call MDA (even from overseas) to receive detailed animations, safety advice, training videos and tips.

The EarDoc from Israel’s Kencap Medical solutions is a non-invasive, non-surgical device that can improve the quality of life for sufferers of earache. It was one of the three previously unreported Israeli innovations featured in the new medical video I distributed last week.

As promised, the second video showing Israeli products previously unreported in this Newsletter. HemaClear for bloodless surgery; RIMED non-invasively measures blood-flow in the brain; FirstCare bone injection gun. More on these in future newsletters.

(Thanks to NoCamels.com) A video showing the design of the remarkable SAGIV device invented by Hebrew University students that provides 100% accurate insertion of intravenous tubes into a person’s veins. (You still may not want to watch this, however, if you have a fear of needles)

The Hebrew University of Jerusalem has signed a research agreement with Philadelphia’s Children’s Hospital and Drexel University to advance pediatric medicine. The event took place during Philadelphia Mayor Michael Nutter’s trade mission to Israel.

Tel Aviv University researchers have found a way to control overactive eosinophil white blood cells - a disorder that can lead to allergies and autoimmune diseases. In lab tests they have located and regulated the two cell receptors PIR-B and PIR-A that protect or shut down the oesinophils.